Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids

Patent metadata

Field	Value
Publication number	US-10136649-B2
Application number	US-201615167727-A
Country	US
Kind code	B2
Filing date	May 27, 2016
Priority date	May 29, 2015
Publication date	Nov 27, 2018
Grant date	Nov 27, 2018

Abstract

This invention relates to the use of CRISPR nucleic acids to screen for essential and non-essential genes and expendable genomic islands in bacteria, archaea, algae and/or yeast, to kill bacteria, archaea, algae and/or yeast, to identify the phenotype of a gene or genes, and/or to screen for reduced genome size and/or a gene deletion in bacteria, archaea, algae and/or yeast.

First claim

That which is claimed is:

1. A method of killing a wild-type bacterial cell having a functional endogenous Cascade-Cas3 CRISPR system within a population of bacterial cells, comprising:
introducing into the population of bacterial cells a heterologous nucleic acid construct comprising a Cascade-Cas3 CRISPR array (crRNA, crDNA) comprising (5′ to 3′) a repeat-spacer-repeat sequence or a repeat-spacer sequence,
wherein the spacer of said repeat-spacer-repeat sequence or said repeat-spacer sequence comprises a nucleotide sequence that is 100% complementary to a target sequence of the wild-type bacterial cell, the target sequence having at least 10 consecutive nucleotides adjacent to a protospacer-adjacent motif (PAM) recognized by the functional endogenous Cascade-Cas3 CRISPR system,
thereby killing the wild-type bacterial cell within the population of bacterial cells;
provided that the following are not introduced into the population of bacterial cells:
(a) an exogenous Cas3 polypeptide that recognizes a complex of Cascade and the Cascade-Cas3 CRISPR array, and an exogenous nucleic acid construct encoding said exogenous Cas3 polypeptide; and
(b) an exogenous Cascade polypeptide that recognizes the Cascade-Cas3 CRISPR array, and an exogenous nucleic acid construct encoding said Cascade polypeptide.

2. The method of claim 1 , wherein the target sequence is within an essential gene.

3. The method of claim 1 , wherein the target sequence is within a non-essential gene.

4. The method of claim 1 , wherein the repeat-spacer-repeat sequence or the repeat-spacer sequence of the Cascade-Cas3 CRISPR array comprises a repeat that is identical to a repeat from a wild-type Cas3 CRISPR array.

5. The method of claim 1 , wherein the target sequence is selected from a gene, an open reading frame, a putative open reading frame, or an intergenic region.

6. The method of claim 1 , wherein at least one bacterial cell in the population of bacterial cells does not comprise the target sequence and, therefore, the bacterial cell is not killed upon introduction of the Cascade-Cas3 CRISPR array.

7. The method of claim 1 , wherein the bacterial cells are selected from the group of bacterial genera of Clostridium, Pseudomonas, Escherichia, Klebsiella, Burkholderia, Prevotella, Acinetobacter , and any combination thereof.

8. The method of claim 1 , wherein the bacterial cells are selected from the group of bacterial species of Clostridium difficile, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Acinetobacter baumanii , and any combination thereof.

Assignees

• Univ North Carolina State

Inventors

• Barrangou Rodolphe
• Selle Kurt M

Classifications

• C12N15/63 Primary

  Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

• C12N15/1034

  Isolating an individual clone by screening libraries · CPC title

• C12N15/1079 Primary

  Screening libraries by altering the phenotype or phenotypic trait of the host (reporter assays C12N15/1086) · CPC title

• A01N37/46

  N-acyl derivatives · CPC title

• A01N63/60

  Isolated nucleic acids · CPC title